SCHEDULE 13G - LIGAND - ORBIMED ADVISORS INC.

Company

LIGAND PHARMACEUTICALS INC

Filed

November 29, 2002

Accession Number

0000947871-02-002352

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →